the importance of cross-reactivity in Grass pollen allerGy

According to the data obtained from in vivo and in vitro testing in Serbia, a significant number of patients have allergic symptoms caused by grass pollen. We examined the protein composition of grass pollens (Dactylis glomerata, Lolium perenne and Phleum pratense) and cross-reactivity in patients allergic to grass pollen from our region. The grass pollen allergen extract was characterized by SDS-PAGE, while cross-reactivity of single grass pollens was revealed by immunoblot analysis. A high degree of cross-reactivity was demonstrated for all three single pollens in the sera of allergic patients compared to the grass pollen extract mixture. Confirmation of the existence of cross-reactivity between different antigenic sources facilitates the use of monovalent vaccines, which are easier to standardize and at the same time prevent further sensitization of patients and reduces adverse reactions. [Projekat Ministarstva nauke Republike Srbije, br. 172049 i br. 172024]

[1]  C. Akdis,et al.  Immunological mechanisms of allergen‐specific immunotherapy , 2011, Allergy.

[2]  H. Ipsen,et al.  Phleum pratense alone is sufficient for allergen‐specific immunotherapy against allergy to Pooideae grass pollens , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  R. Weber.  Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy. , 2008, The Journal of allergy and clinical immunology.

[4]  C. Akdis,et al.  Immunological mechanisms of allergen-specific immunotherapy , 2006, Nature Reviews Immunology.

[5]  E. Harlow,et al.  Immunoblotting: preparing immunoprecipitated proteins. , 2006, Cold Spring Harbor Protocols.

[6]  R. Lockey,et al.  Immunobiology of grass pollen allergens , 2005, Current allergy and asthma reports.

[7]  R. Valenta,et al.  Transition from a Botanical to a Molecular Classification in Tree Pollen Allergy: Implications for Diagnosis and Therapy , 2004, International Archives of Allergy and Immunology.

[8]  R. Valenta,et al.  Renaissance of the Blocking Antibody Concept in Type I Allergy , 2003, International Archives of Allergy and Immunology.

[9]  R. Weber.  Patterns of pollen cross-allergenicity. , 2003, The Journal of allergy and clinical immunology.

[10]  J. Lidholm,et al.  Characteristics and Immunobiology of Grass Pollen Allergens , 2003, International Archives of Allergy and Immunology.

[11]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[12]  R. Van Ree,et al.  How far can we simplify in vitro diagnostics for grass pollen allergy?: A study with 17 whole pollen extracts and purified natural and recombinant major allergens. , 1998, The Journal of allergy and clinical immunology.

[13]  Müller,et al.  Detection and quantification of group 4 allergens in grass pollen extracts using monoclonal antibodies , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  R. Valenta,et al.  IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. , 1998, The Journal of allergy and clinical immunology.

[15]  U Ackermann-Liebrich,et al.  Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. , 1995, International archives of allergy and immunology.

[16]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[17]  R. Knox,et al.  Aerobiology of Grass Pollen in the City Atmosphere of Melbourne: Effects of Weather Parameters and Pollen Sources. , 1979 .